Impact of seizure frequency reduction on health-related quality of life among clinical trial subjects with refractory partial-onset seizures: A pooled analysis of phase III clinical trials of eslicarbazepine acetate

Autor: Velez, Fulton F. a, Bond, T. Christopher b, Anastassopoulos, Kathryn P. b, Wang, Xuezhe b, Sousa, Rui c, Blum, David a, Cramer, Joyce A. d, ⁎
Zdroj: In Epilepsy & Behavior March 2017 68:203-207
Databáze: ScienceDirect
Externí odkaz: